Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?
Publication
, Journal Article
Stefanopoulos, A; Economopoulos, KP
Published in: Tobacco induced diseases
January 2014
Duke Scholars
Published In
Tobacco induced diseases
DOI
EISSN
1617-9625
ISSN
2070-7266
Publication Date
January 2014
Volume
12
Issue
Suppl 1
Start / End Page
A6 / A6
Related Subject Headings
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Stefanopoulos, A., & Economopoulos, K. P. (2014). Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible? Tobacco Induced Diseases, 12(Suppl 1), A6–A6. https://doi.org/10.1186/1617-9625-12-S1-A6
Stefanopoulos, Anastasios, and Konstantinos P. Economopoulos. “Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?” Tobacco Induced Diseases 12, no. Suppl 1 (January 2014): A6–A6. https://doi.org/10.1186/1617-9625-12-S1-A6.
Stefanopoulos A, Economopoulos KP. Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible? Tobacco induced diseases. 2014 Jan;12(Suppl 1):A6–A6.
Stefanopoulos, Anastasios, and Konstantinos P. Economopoulos. “Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?” Tobacco Induced Diseases, vol. 12, no. Suppl 1, Jan. 2014, pp. A6–A6. Epmc, doi:10.1186/1617-9625-12-S1-A6.
Stefanopoulos A, Economopoulos KP. Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible? Tobacco induced diseases. 2014 Jan;12(Suppl 1):A6–A6.
Published In
Tobacco induced diseases
DOI
EISSN
1617-9625
ISSN
2070-7266
Publication Date
January 2014
Volume
12
Issue
Suppl 1
Start / End Page
A6 / A6
Related Subject Headings
- 1103 Clinical Sciences